Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 677 0.30%
29 Apr - close price
medplusindia.com BSE: 543427 NSE : MEDPLUS
About
Key Points

India’s Leading Pharmacy company[1] MedPlus Health Services is the second-largest pharmacy retailer in India in terms of revenue and number of stores. The company has 4089 stores across the states of Telangana (679 stores), Andhra Pradesh (454 stores), Karnataka (893 stores), Tamil Nadu (845 stores), West Bengal (506 stores), Maharashtra (553 stores), and Odisha (149 stores), Chattisgarh (4 stores) Madhya Pradesh (4 stores) as of H1FY24.

Website BSE NSE
  • Market Cap ₹ 8,115 Cr.
  • Current Price ₹ 677
  • High / Low ₹ 978 / 598
  • Stock P/E 1,511
  • Book Value ₹ 96.1
  • Dividend Yield 0.00 %
  • ROCE 1.17 %
  • ROE 0.48 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 18.5% CAGR over last 5 years
  • Company's working capital requirements have reduced from 523 days to 29.7 days

Cons

  • Stock is trading at 7.04 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 0.09% over last 3 years.
  • Promoters have pledged 54.2% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Retail Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
20.57 16.75 25.99 56.20 24.71 38.82 27.29 42.45 57.24 86.95 71.89 98.67 148.10
18.04 16.54 23.96 52.23 25.16 41.05 28.83 42.88 53.50 75.53 69.57 92.40 137.31
Operating Profit 2.53 0.21 2.03 3.97 -0.45 -2.23 -1.54 -0.43 3.74 11.42 2.32 6.27 10.79
OPM % 12.30% 1.25% 7.81% 7.06% -1.82% -5.74% -5.64% -1.01% 6.53% 13.13% 3.23% 6.35% 7.29%
0.54 0.70 0.99 1.22 1.12 6.21 5.37 4.27 4.07 2.54 1.81 1.77 1.82
Interest 0.14 0.27 0.20 0.61 0.64 1.19 1.25 1.46 1.79 2.05 2.08 2.11 2.10
Depreciation 0.28 0.50 0.52 1.01 1.24 1.86 2.54 3.20 4.24 5.33 5.54 5.97 6.27
Profit before tax 2.65 0.14 2.30 3.57 -1.21 0.93 0.04 -0.82 1.78 6.58 -3.49 -0.04 4.24
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 65.17% 13.37% 0.00% 0.00% 24.76%
2.65 0.15 2.31 3.56 -1.21 0.92 0.04 -0.82 0.62 5.71 -3.49 -0.04 3.19
EPS in Rs 130.09 3.27 50.39 1.11 -0.10 0.08 0.00 -0.07 0.05 0.48 -0.29 -0.00 0.27
Raw PDF
Upcoming result date: 28 May 2024

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
2 2 2 9 10 61 68 146 214 406
6 7 4 14 13 86 77 142 201 375
Operating Profit -3 -5 -2 -5 -3 -25 -9 3 13 31
OPM % -137% -225% -89% -52% -36% -41% -13% 2% 6% 8%
-1 1 0 1 1 2 2 10 16 8
Interest 1 0 0 12 0 0 1 3 7 8
Depreciation 0 0 0 0 0 1 1 5 15 23
Profit before tax -5 -4 -2 -16 -3 -24 -9 6 8 7
Tax % 0% 0% 0% 0% 0% -2% 0% 0% 27%
-5 -4 -2 -16 -3 -25 -9 6 6 5
EPS in Rs -292.30 -241.71 -109.61 -793.71 -126.23 -1,220.91 -186.95 0.47 0.46 0.46
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 87%
3 Years: 52%
TTM: 145%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 30%
TTM: 607%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -8%
Return on Equity
10 Years: %
5 Years: -1%
3 Years: 0%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 0 0 0 0 0 0 24 24 24
Reserves 126 108 88 185 185 395 517 1,089 1,117 1,125
Preference Capital 12 12 12 0 0 0 0 0 0
43 43 43 0 0 3 7 44 86 88
18 33 51 3 6 17 24 30 45 59
Total Liabilities 187 185 183 189 192 415 548 1,187 1,272 1,297
1 1 0 0 0 7 23 85 179 195
CWIP 0 0 0 0 0 1 2 16 18 4
Investments 153 177 177 181 186 381 408 418 917 925
34 6 5 8 5 26 115 668 157 173
Total Assets 187 185 183 189 192 415 548 1,187 1,272 1,297

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-5 -4 -2 -1 -1 3 -6 -18 11
-11 -24 0 -2 -3 -197 -15 -636 32
46 0 0 7 0 204 97 569 -8
Net Cash Flow 30 -28 -1 4 -4 10 76 -86 35

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 32 29 14 22 80 51 62 53 64
Inventory Days 33 35 12 16
Days Payable 9 17 17 30
Cash Conversion Cycle 32 29 14 22 80 75 79 48 50
Working Capital Days -78 -72 -130 -97 -145 -11 -16 1,554 30
ROCE % -2% -1% -2% -1% -8% -2% 1% 1%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.41% 40.45% 40.39%
3.42% 2.97% 3.15% 3.74% 3.94% 4.48% 4.87% 12.36% 12.96% 14.94%
27.72% 29.24% 29.48% 28.84% 28.77% 28.16% 28.13% 25.50% 25.19% 22.47%
28.08% 27.01% 26.58% 26.64% 26.56% 26.73% 26.42% 21.61% 21.31% 22.10%
0.35% 0.35% 0.35% 0.35% 0.29% 0.19% 0.15% 0.12% 0.10% 0.10%
No. of Shareholders 1,02,77982,62777,11976,97274,70273,51270,01766,43066,04874,976

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls